K
Karri Barabas
Researcher at University of Florida
Publications - 3
Citations - 386
Karri Barabas is an academic researcher from University of Florida. The author has contributed to research in topics: Nephrotoxicity & Induction chemotherapy. The author has an hindex of 3, co-authored 3 publications receiving 327 citations.
Papers
More filters
Journal ArticleDOI
Cisplatin: a review of toxicities and therapeutic applications.
TL;DR: Cisplatin is a platinum chemotherapeutic used in a variety of malignancies and has shown activity against osteosarcoma, transitional cell carcinomas, squamous cell carcinoma (SCC), melanoma, mesothelioma, carcinomatosis and germinal cell tumours in the dog and in the cat.
Journal ArticleDOI
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Christine E. Fahey,Rowan J. Milner,Karri Barabas,David M. Lurie,Kelvin Kow,Shannon Parfitt,Sarah E. Lyles,Monica Clemente +7 more
TL;DR: The University of Florida LOPP protocol may be an acceptable alternative to the mechlorethamine, vincristine, procarbazine, and prednisone protocol as a rescue protocol for dogs with lymphoma.
Journal ArticleDOI
Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat.
Karri Barabas,Rowan J. Milner,James P. Farese,Chris Baylis,Byron P. Croker,Linda L. Archer,Christopher A. Adin +6 more
TL;DR: Hyperbilirubinemia in the Gunn rat provided marked preservation of renal function and histology in a cisplatin nephrotoxicity model and provided a nephroprotective effect, with significantly lower BUN and creatinine in Gunn j/j when compared with Wistar rats at day 5.